+1 650 843 5491 jstellini@cooley.com
John Stellini has a general corporate and securities law practice, with an emphasis on the representation of emerging companies, venture capital funds and public companies.
Download full bio
Eiger BioPharmaceuticals: $49 Million Follow-On
Cytokinetics: $138 Million Convertible Senior Notes
Lively: $11 Million Series A Financing
Emerging Companies
Venture Capital
Santa Clara University School of LawJD, 2017
University of ArizonaBA, Political Science2014
California
Kaleyra to Combine With Special Purpose Acquisition Company GigCapital March 8, 2019
Clearlake to Acquire Symplr November 5, 2018
Clearlake Capital Closes Pair of Key Acquisitions October 24, 2018
State Bar of California
+1 650 843 5491 office jstellini@cooley.com
3175 Hanover StreetPalo Alto, CA 94304-1130